Blood Screening and Typing: Global Markets
REPORT SCOPE:
This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.
By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.
By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.
REPORT INCLUDES:
This report focuses on the screening and analysis of donor blood and patient blood. It covers the current market dynamics and various forces that are impacting the market. Two markets are analyzed: blood screening and blood typing. By technology, the blood screening market is segmented into serological technologies Enzyme linked immunosorbent assay (ELISA) and chemiluminescence immunoassay (CLIA), agglutination tests such as gel card agglutination, microplate-based agglutination, and lateral flow tests), nucleic acid amplification technologies (PCR-based and non-PCR based), microbiology techniques (blood culture and antimicrobial susceptibility tests) and niche technologies such as microarray, DNA sequencing.
By blood supply, the market is segmented into patient blood and donor blood. Patient blood supply analysis covers the qualitative detection of infectious diseases such as sexually transmitted diseases and blood-borne infections like sepsis, and blood grouping and typing analysis tests. Donor blood testing involves analysis of donor blood units, including infectious disease screening and blood grouping tests.
By end-user the market is segmented into hospitals, standalone blood banks and reference laboratories. By region, the blood screening and typing market is segmented into North America, Europe, the Asia-Pacific region and Rest of the World (ROW). ROW includes South America, the Middle East and Africa. This report also covers the competitive landscape, detailing the companies engaged in offering products for blood screening and typing. Detailed profiles of the top leading companies are also included.
REPORT INCLUDES:
- 31 data tables and 34 additional tables
- An overview of recent key developments in the global blood screening and typing market and a look ahead at the next five years
- Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Quantitative data covering the overall market by analyzers, kits, reagents and consumables, immunoassay techniques, technology types, microbiology techniques, blood types and consumer groups
- Regional dynamics of the blood screening market covering North America, Europe, Asia-Pacific and Rest of the world including countries of South America, Middle East and Africa
- Study of impact analysis and discussion of technological, regulatory, and economic trends that are affecting the global blood screening market
- Company profiles of the leading market players, including Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Danaher Corp. and Thermo Fisher Scientific, Inc.
CHAPTER 1 INTRODUCTION
Scope of Report
Inclusions
Exclusions
Information Sources
Methodology
Market Estimation and Forecast
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Key Findings
CHAPTER 3 BLOOD INDUSTRY LANDSCAPE
Overview of Blood
Composition of Blood
Functions of Blood
Classification of Blood Groups
ABO Blood Group
H Antigen
Rhesus System
MNS System
Lutheran System
Kell System
Duffy Antigen System
Kidd Antigen
Blood Collection and Transfusion
Types of Blood Establishments and Blood Facilities
Methods for Collecting Blood from a Donor
Plasma Collection
Blood Transfusions
Types of Transfusions
Complications Associated with Blood Transfusions
Transfusion Transmissible Infections
National Healthcare Safety Network-Biovigilance Component Hemovigilance Module Surveillance
Diseases Contracted from Blood Transfusions and Related Identification Testing
Human Immunodeficiency Virus (HIV)
Epidemiology of Sexually Transmittable Diseases
Blood Screening and Evaluation
Efforts to Create a Virus-Free Blood Supply
Negative Reactions from Blood Transfusions
Blood/Plasma Component Risks
Blood Management Issues
Availability Issues
Bloodless Surgery
Safety Issues: Risk Management
Blood-Transfusion Fatalities
CHAPTER 4 MARKET DEFINITION AND DYNAMICS
Definition
Blood Screening
Blood Grouping and Typing
Market Drivers
Increasing Incidence of Chronic Diseases and Infections
Demand for Blood and Blood Transfusion Services
Favorable Safety Regulatory Policies for Blood Products
Increase in Automation
Market Restraints
Government Policies
Price Pressure on Manufacturers
Shortage of Skilled Laboratory Technicians
Emerging Trends and Opportunities
Multiplexing for Blood Screening
Development of Novel Technologies: DNA Sequencing and Microarray Technologies
CHAPTER 5 MARKET SEGMENT ANALYSIS
Segment Analysis, by Technology
Immunoassay
Market Size and Forecast
Nucleic Acid Amplification Technology
Polymerase Chain Reaction Amplification
Other Nucleic Acid Amplification Technologies
Market Size and Forecast
Immunohematology (Blood Typing) Techniques
Manual Typing Methods
Automated Blood Typing
Market Size and Forecast
Microbial Techniques
Blood Stream Infections
Blood Cell Culture and Antimicrobial Susceptibility Testing
BioMerieux’s VITEK 2 System
Becton, Dickinson and Company’s BD Phoenix Identification and Susceptibility Testing System
Market Size and Forecast
Niche Emerging Technologies
DNA Sequencing
Microarray
Market Size and Forecast
Segment Analysis, by End User
Reference Laboratories
Standalone Blood Banks
Hospitals
Segment Analysis, by Blood Type
Donor Blood
Patient Blood
CHAPTER 6 MARKET BREAKDOWN BY REGION
Introduction and Regional Markets
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of the World (RoW)
South America
Middle East and Africa
CHAPTER 7 REGULATORY AND REIMBURSEMENT LANDSCAPE
Regulations in United States
Statutory Authority of the FDA
Major Regulations and Policy Matters Concerning the U.S. Blood Supply
Implementation of Regulations
Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and Blood Components
Other Organizations Involved in Blood Regulation
Voluntary Regulation, by Professional and Trade Associations
Reimbursement Landscape in United States
Preventive Care Services
Regulations in Europe
The International Society for Blood Transfusion: ISBT
Regulations in the Asia-Pacific
Regulations in Central and South America
Regulations in the Middle East and Africa
CHAPTER 8 MARKET SHARE ANALYSIS AND RECENT INDUSTRY DEVELOPMENTS
Market Share Analysis
Market Share Analysis in the Nucleic Acid Test Segment
Market Share Analysis in the Immunoassay Tests Segment
Market Share Analysis in the Immunohematology Segment
Market Share Analysis in the Microbiology Segment
Recent Industry Developments
CHAPTER 9 COMPANY PROFILES
ABBOTT LABORATORIES
AGENA BIOSCIENCE
AXO SCIENCE
BAG HEALTH CARE GMBH
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES
BIOMЙRIEUX SA
DANAHER CORP.
DAY MEDICAL SA
DIAGAST
F. HOFFMANN-LA ROCHE LTD.
GRIFOLS S.A.
IMMUCOR
NOVACYT GROUP
ORTHO CLINICAL DIAGNOSTICS
QUOTIENT
SIEMENS HEALTHCARE GMBH
THERMO FISHER SCIENTIFIC, INC.
Scope of Report
Inclusions
Exclusions
Information Sources
Methodology
Market Estimation and Forecast
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Key Findings
CHAPTER 3 BLOOD INDUSTRY LANDSCAPE
Overview of Blood
Composition of Blood
Functions of Blood
Classification of Blood Groups
ABO Blood Group
H Antigen
Rhesus System
MNS System
Lutheran System
Kell System
Duffy Antigen System
Kidd Antigen
Blood Collection and Transfusion
Types of Blood Establishments and Blood Facilities
Methods for Collecting Blood from a Donor
Plasma Collection
Blood Transfusions
Types of Transfusions
Complications Associated with Blood Transfusions
Transfusion Transmissible Infections
National Healthcare Safety Network-Biovigilance Component Hemovigilance Module Surveillance
Diseases Contracted from Blood Transfusions and Related Identification Testing
Human Immunodeficiency Virus (HIV)
Epidemiology of Sexually Transmittable Diseases
Blood Screening and Evaluation
Efforts to Create a Virus-Free Blood Supply
Negative Reactions from Blood Transfusions
Blood/Plasma Component Risks
Blood Management Issues
Availability Issues
Bloodless Surgery
Safety Issues: Risk Management
Blood-Transfusion Fatalities
CHAPTER 4 MARKET DEFINITION AND DYNAMICS
Definition
Blood Screening
Blood Grouping and Typing
Market Drivers
Increasing Incidence of Chronic Diseases and Infections
Demand for Blood and Blood Transfusion Services
Favorable Safety Regulatory Policies for Blood Products
Increase in Automation
Market Restraints
Government Policies
Price Pressure on Manufacturers
Shortage of Skilled Laboratory Technicians
Emerging Trends and Opportunities
Multiplexing for Blood Screening
Development of Novel Technologies: DNA Sequencing and Microarray Technologies
CHAPTER 5 MARKET SEGMENT ANALYSIS
Segment Analysis, by Technology
Immunoassay
Market Size and Forecast
Nucleic Acid Amplification Technology
Polymerase Chain Reaction Amplification
Other Nucleic Acid Amplification Technologies
Market Size and Forecast
Immunohematology (Blood Typing) Techniques
Manual Typing Methods
Automated Blood Typing
Market Size and Forecast
Microbial Techniques
Blood Stream Infections
Blood Cell Culture and Antimicrobial Susceptibility Testing
BioMerieux’s VITEK 2 System
Becton, Dickinson and Company’s BD Phoenix Identification and Susceptibility Testing System
Market Size and Forecast
Niche Emerging Technologies
DNA Sequencing
Microarray
Market Size and Forecast
Segment Analysis, by End User
Reference Laboratories
Standalone Blood Banks
Hospitals
Segment Analysis, by Blood Type
Donor Blood
Patient Blood
CHAPTER 6 MARKET BREAKDOWN BY REGION
Introduction and Regional Markets
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of the World (RoW)
South America
Middle East and Africa
CHAPTER 7 REGULATORY AND REIMBURSEMENT LANDSCAPE
Regulations in United States
Statutory Authority of the FDA
Major Regulations and Policy Matters Concerning the U.S. Blood Supply
Implementation of Regulations
Guidance for Industry Recognition and Use of a Standard for the Uniform Labeling of Blood and Blood Components
Other Organizations Involved in Blood Regulation
Voluntary Regulation, by Professional and Trade Associations
Reimbursement Landscape in United States
Preventive Care Services
Regulations in Europe
The International Society for Blood Transfusion: ISBT
Regulations in the Asia-Pacific
Regulations in Central and South America
Regulations in the Middle East and Africa
CHAPTER 8 MARKET SHARE ANALYSIS AND RECENT INDUSTRY DEVELOPMENTS
Market Share Analysis
Market Share Analysis in the Nucleic Acid Test Segment
Market Share Analysis in the Immunoassay Tests Segment
Market Share Analysis in the Immunohematology Segment
Market Share Analysis in the Microbiology Segment
Recent Industry Developments
CHAPTER 9 COMPANY PROFILES
ABBOTT LABORATORIES
AGENA BIOSCIENCE
AXO SCIENCE
BAG HEALTH CARE GMBH
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES
BIOMЙRIEUX SA
DANAHER CORP.
DAY MEDICAL SA
DIAGAST
F. HOFFMANN-LA ROCHE LTD.
GRIFOLS S.A.
IMMUCOR
NOVACYT GROUP
ORTHO CLINICAL DIAGNOSTICS
QUOTIENT
SIEMENS HEALTHCARE GMBH
THERMO FISHER SCIENTIFIC, INC.
LIST OF TABLES
Summary Table: Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 1: Composition of Blood Plasma
Table 2: Types of Cellular Elements Present in Blood
Table 3: Diseases That can be Treated with Plasmapheresis
Table 4: Red Blood Cells Compatibility
Table 5: Compatibility of ABO and RH Systems
Table 6: Selected Uses of Fresh Frozen Plasma
Table 7: Usage and Therapeutic Effect of Cryoprecipitate
Table 8: U.S. Major Diseases Contracted from Blood Transfusions
Table 9: Chlamydia Incidence in Selected Countries, 2012-2017
Table 10: Global HSV-1 Prevalence, Aged 0-49 years, 2012
Table 11: Gonorrhea Epidemiology in Selected Countries, 2012-2017
Table 12: HIV Incidence, by Country, 2005-2016
Table 13: Syphilis Incidence, by Country, 2013-2016
Table 14: Factors to Reduce Risks of Transfusion-Associated Diseases
Table 15: Transfusion-Related Fatalities, by Complication, 2008-2013
Table 16: Fatalities Not Related to Transfusion or Transfusion Not Ruled Out, FY2008-FY2013
Table 17: Post-Donation “Not Ruled Out” Fatality Reports, by Donated Product, FY2008-FY2013
Table 18: Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 19: Global Market for Immunoassay Tests, by Region, Through 2023
Table 20: Selected PCR Screening Tests, by Type
Table 21: Global Market for Nucleic Acid Amplification Technology, by Region, Through 2023
Table 22: Global Market for Immunohematology Devices, by Region, Through 2023
Table 23: Global Market for Microbial Techniques, by Region, Through 2023
Table 24: Global Market for Niche Technologies, by Region, Through 2023
Table 25: Global Market for Blood Screening and Typing, by End User, Through 2023
Table 26: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, Through 2023
Table 27: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, Through 2023
Table 28: Global Market for Blood Screening and Typing in Hospitals, by Region, Through 2023
Table 29: Global Market for Blood Screening and Typing, by Type, Through 2023
Table 30: Global Market for Donor Blood Testing Equipment, by Region, Through 2023
Table 31: Global Market for Patient Blood Testing Equipment, by Region, Through 2023
Table 32: Global Market for Blood Screening and Typing, by Region, Through 2023
Table 33: North American Market for Blood Screening and Typing, by Country, Through 2023
Table 34: European Market for Blood Screening and Typing, by Country, Through 2023
Table 35: Asia-Pacific Market for Blood Screening and Typing, by Country, Through 2023
Table 36: Donation and Distribution (JRCS 2015)
Table 37: RoW Market for Blood Screening and Typing, by Country, Through 2023
Table 38: Federal Organizations Responsible for U.S. Blood Safety
Table 39: FDA Authority in Regulating Blood Banking and Blood Products
Table 40: Major Areas of Concern for Inspecting Blood Facilities
Table 41: Classification of In Vitro Diagnostic Devices Under the European IVDR
Table 42: Leading Companies, by Technology Segment
Table 43: Recent Industry Developments, February 2016-December 2018
Table 44: Abbott Laboratories: Company Net Revenue, 2015-2017
Table 45: Abbott Laboratories: Products
Table 46: Becton, Dickinson and Co.: Company Net Revenue, 2015-2017
Table 47: Becton, Dickinson and Co.: Products and Services
Table 48: Bio-Rad Laboratories: Company Net Revenue, 2015-2017
Table 49: Bio-Rad Laboratories: Products and Services
Table 50: Biomйrieux SA: Company Net Revenue, 2015-2017
Table 51: BioMйrieux SA: Products and Services
Table 52: Danaher Corp.: Company Net Revenue, 2015-2017
Table 53: Danaher Corp.: Products and Services
Table 54: F. Hofmann-La Roche Ltd.: Company Net Revenue, 2015-2017
Table 55: F. Hofmann-La Roche Ltd.: Products and Services
Table 56: Grifols S.A: Company Net Revenue, 2015-2017
Table 57: Grifols S.A: Products and Services
Table 58: Immucor: Company Net Revenue, 2014-2016
Table 59: Immucor: Products and Services
Table 60: Ortho Clinical: Diagnostics Products and Services
Table 61: Siemens Healthineers GmbH: Company Net Revenue, 2015-2017
Table 62: Siemens Healthineers GmbH: Products and Services
Table 63: Thermo Fisher Scientific, Inc.: Company Net Revenue, 2015-2017
Table 64: Thermo Fischer Scientific, Inc.: Products and Services
Summary Table: Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 1: Composition of Blood Plasma
Table 2: Types of Cellular Elements Present in Blood
Table 3: Diseases That can be Treated with Plasmapheresis
Table 4: Red Blood Cells Compatibility
Table 5: Compatibility of ABO and RH Systems
Table 6: Selected Uses of Fresh Frozen Plasma
Table 7: Usage and Therapeutic Effect of Cryoprecipitate
Table 8: U.S. Major Diseases Contracted from Blood Transfusions
Table 9: Chlamydia Incidence in Selected Countries, 2012-2017
Table 10: Global HSV-1 Prevalence, Aged 0-49 years, 2012
Table 11: Gonorrhea Epidemiology in Selected Countries, 2012-2017
Table 12: HIV Incidence, by Country, 2005-2016
Table 13: Syphilis Incidence, by Country, 2013-2016
Table 14: Factors to Reduce Risks of Transfusion-Associated Diseases
Table 15: Transfusion-Related Fatalities, by Complication, 2008-2013
Table 16: Fatalities Not Related to Transfusion or Transfusion Not Ruled Out, FY2008-FY2013
Table 17: Post-Donation “Not Ruled Out” Fatality Reports, by Donated Product, FY2008-FY2013
Table 18: Global Market for Blood Screening and Typing, by Technology, Through 2023
Table 19: Global Market for Immunoassay Tests, by Region, Through 2023
Table 20: Selected PCR Screening Tests, by Type
Table 21: Global Market for Nucleic Acid Amplification Technology, by Region, Through 2023
Table 22: Global Market for Immunohematology Devices, by Region, Through 2023
Table 23: Global Market for Microbial Techniques, by Region, Through 2023
Table 24: Global Market for Niche Technologies, by Region, Through 2023
Table 25: Global Market for Blood Screening and Typing, by End User, Through 2023
Table 26: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, Through 2023
Table 27: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, Through 2023
Table 28: Global Market for Blood Screening and Typing in Hospitals, by Region, Through 2023
Table 29: Global Market for Blood Screening and Typing, by Type, Through 2023
Table 30: Global Market for Donor Blood Testing Equipment, by Region, Through 2023
Table 31: Global Market for Patient Blood Testing Equipment, by Region, Through 2023
Table 32: Global Market for Blood Screening and Typing, by Region, Through 2023
Table 33: North American Market for Blood Screening and Typing, by Country, Through 2023
Table 34: European Market for Blood Screening and Typing, by Country, Through 2023
Table 35: Asia-Pacific Market for Blood Screening and Typing, by Country, Through 2023
Table 36: Donation and Distribution (JRCS 2015)
Table 37: RoW Market for Blood Screening and Typing, by Country, Through 2023
Table 38: Federal Organizations Responsible for U.S. Blood Safety
Table 39: FDA Authority in Regulating Blood Banking and Blood Products
Table 40: Major Areas of Concern for Inspecting Blood Facilities
Table 41: Classification of In Vitro Diagnostic Devices Under the European IVDR
Table 42: Leading Companies, by Technology Segment
Table 43: Recent Industry Developments, February 2016-December 2018
Table 44: Abbott Laboratories: Company Net Revenue, 2015-2017
Table 45: Abbott Laboratories: Products
Table 46: Becton, Dickinson and Co.: Company Net Revenue, 2015-2017
Table 47: Becton, Dickinson and Co.: Products and Services
Table 48: Bio-Rad Laboratories: Company Net Revenue, 2015-2017
Table 49: Bio-Rad Laboratories: Products and Services
Table 50: Biomйrieux SA: Company Net Revenue, 2015-2017
Table 51: BioMйrieux SA: Products and Services
Table 52: Danaher Corp.: Company Net Revenue, 2015-2017
Table 53: Danaher Corp.: Products and Services
Table 54: F. Hofmann-La Roche Ltd.: Company Net Revenue, 2015-2017
Table 55: F. Hofmann-La Roche Ltd.: Products and Services
Table 56: Grifols S.A: Company Net Revenue, 2015-2017
Table 57: Grifols S.A: Products and Services
Table 58: Immucor: Company Net Revenue, 2014-2016
Table 59: Immucor: Products and Services
Table 60: Ortho Clinical: Diagnostics Products and Services
Table 61: Siemens Healthineers GmbH: Company Net Revenue, 2015-2017
Table 62: Siemens Healthineers GmbH: Products and Services
Table 63: Thermo Fisher Scientific, Inc.: Company Net Revenue, 2015-2017
Table 64: Thermo Fischer Scientific, Inc.: Products and Services
LIST OF FIGURES
Summary Figure A: Global Market for Blood Screening and Typing, by Technology, 2017-2023
Summary Figure B: Global Market Share for Blood Screening and Typing, by Technology, 2017
Figure 1: HIV Infected Population, by Region, 2016
Figure 2: Projected Increase in Workforce Needs in the U.S., 2016-2026
Figure 3: Global Market for Blood Screening and Typing, by Technology, 2017-2023
Figure 4: Global Market Share for Blood Screening and Typing, by Technology, 2017
Figure 5: Global Market for Immunoassay Tests, by Region, 2017-2023
Figure 6: Global Market Share for Immunoassay Tests, by Region, 2017
Figure 7: Global Market for Nucleic Acid Amplification Technology, by Region, 2017-2023
Figure 8: Global Market Share for Nucleic Acid Amplification Technology, by Region, 2017
Figure 9: Global Market for Immunohematology Devices, by Region, 2017-2023
Figure 10: Global Market Share for Immunohematology Devices, by Region, 2017
Figure 11: Global Market for Microbial Techniques, by Region, 2017-2023
Figure 12: Global Market Share for Microbial Techniques, by Region, 2017
Figure 13: Global Market for Niche Technologies, by Region, Through 2023
Figure 14: Global Market Share for Niche Technologies, by Region, 2017
Figure 15: Global Market for Blood Screening and Typing, by End User, 2017-2023
Figure 16: Global Market Share for Blood Screening and Typing, by End User, 2017
Figure 17: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, 2017-2023
Figure 18: Global Market Share for Blood Screening and Typing in Reference Laboratories, by Region, 2017
Figure 19: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017-2023
Figure 20: Global Market Share for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017
Figure 21: Global Market for Blood Screening and Typing in Hospitals, by Region, 2017-2023
Figure 22: Global Market Share for Blood Screening and Typing in Hospitals, by Region, 2017
Figure 23: Global Market for Blood Screening and Typing, by Type, 2017-2023
Figure 24: Global Market Share for Blood Screening and Typing, by Type, 2017
Figure 25: Global Market for Donor Blood Testing Equipment, by Region, 2017-2023
Figure 26: Global Market Share for Donor Blood Testing Equipment, by Region, 2017
Figure 27: Global Market for Patient Blood Testing Equipment, by Region, 2017-2023
Figure 28: Global Market Share for Patient Blood Testing Equipment, by Region, 2017
Figure 29: Global Market for Blood Screening and Typing, by Region, 2017-2023
Figure 30: Global Market Share for Blood Screening and Typing, by Region, 2017
Figure 31: North American Market for Blood Screening and Typing, by Country, 2017-2023
Figure 32: North American Market Share for Blood Screening and Typing, by Country, 2017
Figure 33: European Market for Blood Screening and Typing, by Country, 2017-2023
Figure 34: European Market Share for Blood Screening and Typing, by Country, 2017
Figure 35: Asia-Pacific Market for Blood Screening and Typing, by Country, 2017-2023
Figure 36: Asia-Pacific Market Share for Blood Screening and Typing, by Country, 2017
Figure 37: RoW Market for Blood Screening and Typing, by Country, 2017-2023
Figure 38: RoW Market Share for Blood Screening and Typing, by Country, 2017
Figure 39: Global Market Share Analysis of Blood Screening and Typing, by Company, 2017
Figure 40: Nucleic Acid Test, Market Share Analysis, by Company, 2017
Figure 41: Immunoassay Tests, Market Share Analysis, by Company, 2017
Figure 42: Immunohematology, Market Share Analysis, by Company, 2017
Figure 43: Microbiology, Market Share Analysis, by Company, 2017
Figure 44: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
Figure 45: Abbott Laboratories: Revenue, by Country, 2015-2017
Figure 46: Abbott Laboratories: Revenue Share, by Diagnostics Segment, 2017
Figure 47: Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2017
Figure 48: Becton, Dickinson and Co.: Revenue Share, by Region/Country, 2017
Figure 49: Bio-Rad Laboratories: Revenue, by Business Segment, 2015-2017
Figure 50: Bio-Rad Laboratories: Revenue, by Region/Country, 2015-2017
Figure 51: Bio-Rad Laboratories Revenue Share, by Region/Country, 2017
Figure 52: BioMйrieux SA: Revenue, by Business Segment, 2015-2017
Figure 53: BioMйrieux SA: Revenue, by Region, 2015-2017
Figure 54: Danaher Corp.: Revenue, by Business Segment, 2015-2017
Figure 55: Danaher Corp.: Revenue, by Region, 2015-2017
Figure 56: Danaher Corp.: Revenue Share, by Diagnostics, 2017
Figure 57: Danaher Corp.: Revenue Share, by Region, 2017
Figure 58: F. Hofmann-La Roche Ltd.: Revenue, by Business Segment, 2015-2017
Figure 59: F. Hofmann-La Roche Ltd.: Revenue, by Diagnostics Segment, 2015-2017
Figure 60: F. Hofmann-La Roche Ltd.: Revenue, by Region, 2015-2017
Figure 61: Grifols S.A: Revenue, by Business Segment, 2015-2017
Figure 62: Grifols S.A: Revenue Share, by Business Segment, 2015-2017
Figure 63: Immucor: Revenue, by Business Segment, 2014-2016
Figure 64: Immucor: Revenue, by Region/Country, 2014-2016
Figure 65: Siemens Healthineers GmbH: Revenue, by Business Segment, 2015-2017
Figure 66: Siemens Healthineers GmbH: Revenue Share, by Business Segment, 2017
Figure 67: Siemens Healthineers GmbH: Revenue Share, by Diagnostics Segment, 2017
Figure 68: Siemens Healthineers GmbH: Revenue Share, by Region, 2017
Figure 69: Thermo Fischer Scientific, Inc.: Revenue Share, by Business Unit, 2017
Figure 70: Thermo Fischer Scientific, Inc.: Revenue Share, by Country, 2017
Summary Figure A: Global Market for Blood Screening and Typing, by Technology, 2017-2023
Summary Figure B: Global Market Share for Blood Screening and Typing, by Technology, 2017
Figure 1: HIV Infected Population, by Region, 2016
Figure 2: Projected Increase in Workforce Needs in the U.S., 2016-2026
Figure 3: Global Market for Blood Screening and Typing, by Technology, 2017-2023
Figure 4: Global Market Share for Blood Screening and Typing, by Technology, 2017
Figure 5: Global Market for Immunoassay Tests, by Region, 2017-2023
Figure 6: Global Market Share for Immunoassay Tests, by Region, 2017
Figure 7: Global Market for Nucleic Acid Amplification Technology, by Region, 2017-2023
Figure 8: Global Market Share for Nucleic Acid Amplification Technology, by Region, 2017
Figure 9: Global Market for Immunohematology Devices, by Region, 2017-2023
Figure 10: Global Market Share for Immunohematology Devices, by Region, 2017
Figure 11: Global Market for Microbial Techniques, by Region, 2017-2023
Figure 12: Global Market Share for Microbial Techniques, by Region, 2017
Figure 13: Global Market for Niche Technologies, by Region, Through 2023
Figure 14: Global Market Share for Niche Technologies, by Region, 2017
Figure 15: Global Market for Blood Screening and Typing, by End User, 2017-2023
Figure 16: Global Market Share for Blood Screening and Typing, by End User, 2017
Figure 17: Global Market for Blood Screening and Typing in Reference Laboratories, by Region, 2017-2023
Figure 18: Global Market Share for Blood Screening and Typing in Reference Laboratories, by Region, 2017
Figure 19: Global Market for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017-2023
Figure 20: Global Market Share for Blood Screening and Typing in Standalone Blood Banks, by Region, 2017
Figure 21: Global Market for Blood Screening and Typing in Hospitals, by Region, 2017-2023
Figure 22: Global Market Share for Blood Screening and Typing in Hospitals, by Region, 2017
Figure 23: Global Market for Blood Screening and Typing, by Type, 2017-2023
Figure 24: Global Market Share for Blood Screening and Typing, by Type, 2017
Figure 25: Global Market for Donor Blood Testing Equipment, by Region, 2017-2023
Figure 26: Global Market Share for Donor Blood Testing Equipment, by Region, 2017
Figure 27: Global Market for Patient Blood Testing Equipment, by Region, 2017-2023
Figure 28: Global Market Share for Patient Blood Testing Equipment, by Region, 2017
Figure 29: Global Market for Blood Screening and Typing, by Region, 2017-2023
Figure 30: Global Market Share for Blood Screening and Typing, by Region, 2017
Figure 31: North American Market for Blood Screening and Typing, by Country, 2017-2023
Figure 32: North American Market Share for Blood Screening and Typing, by Country, 2017
Figure 33: European Market for Blood Screening and Typing, by Country, 2017-2023
Figure 34: European Market Share for Blood Screening and Typing, by Country, 2017
Figure 35: Asia-Pacific Market for Blood Screening and Typing, by Country, 2017-2023
Figure 36: Asia-Pacific Market Share for Blood Screening and Typing, by Country, 2017
Figure 37: RoW Market for Blood Screening and Typing, by Country, 2017-2023
Figure 38: RoW Market Share for Blood Screening and Typing, by Country, 2017
Figure 39: Global Market Share Analysis of Blood Screening and Typing, by Company, 2017
Figure 40: Nucleic Acid Test, Market Share Analysis, by Company, 2017
Figure 41: Immunoassay Tests, Market Share Analysis, by Company, 2017
Figure 42: Immunohematology, Market Share Analysis, by Company, 2017
Figure 43: Microbiology, Market Share Analysis, by Company, 2017
Figure 44: Abbott Laboratories: Revenue, by Business Segment, 2015-2017
Figure 45: Abbott Laboratories: Revenue, by Country, 2015-2017
Figure 46: Abbott Laboratories: Revenue Share, by Diagnostics Segment, 2017
Figure 47: Becton, Dickinson and Co.: Revenue Share, by Business Segment, 2017
Figure 48: Becton, Dickinson and Co.: Revenue Share, by Region/Country, 2017
Figure 49: Bio-Rad Laboratories: Revenue, by Business Segment, 2015-2017
Figure 50: Bio-Rad Laboratories: Revenue, by Region/Country, 2015-2017
Figure 51: Bio-Rad Laboratories Revenue Share, by Region/Country, 2017
Figure 52: BioMйrieux SA: Revenue, by Business Segment, 2015-2017
Figure 53: BioMйrieux SA: Revenue, by Region, 2015-2017
Figure 54: Danaher Corp.: Revenue, by Business Segment, 2015-2017
Figure 55: Danaher Corp.: Revenue, by Region, 2015-2017
Figure 56: Danaher Corp.: Revenue Share, by Diagnostics, 2017
Figure 57: Danaher Corp.: Revenue Share, by Region, 2017
Figure 58: F. Hofmann-La Roche Ltd.: Revenue, by Business Segment, 2015-2017
Figure 59: F. Hofmann-La Roche Ltd.: Revenue, by Diagnostics Segment, 2015-2017
Figure 60: F. Hofmann-La Roche Ltd.: Revenue, by Region, 2015-2017
Figure 61: Grifols S.A: Revenue, by Business Segment, 2015-2017
Figure 62: Grifols S.A: Revenue Share, by Business Segment, 2015-2017
Figure 63: Immucor: Revenue, by Business Segment, 2014-2016
Figure 64: Immucor: Revenue, by Region/Country, 2014-2016
Figure 65: Siemens Healthineers GmbH: Revenue, by Business Segment, 2015-2017
Figure 66: Siemens Healthineers GmbH: Revenue Share, by Business Segment, 2017
Figure 67: Siemens Healthineers GmbH: Revenue Share, by Diagnostics Segment, 2017
Figure 68: Siemens Healthineers GmbH: Revenue Share, by Region, 2017
Figure 69: Thermo Fischer Scientific, Inc.: Revenue Share, by Business Unit, 2017
Figure 70: Thermo Fischer Scientific, Inc.: Revenue Share, by Country, 2017
